A Phase II Study of Paclitaxel+Cisplatin+5-Fluorouracil in Unresectable Advanced or Recurrent Gastric Cancer
Not Applicable
- Conditions
- nresectable Advanced or Recurrent Gastric Cancer
- Registration Number
- JPRN-UMIN000002988
- Lead Sponsor
- on profit foundation: Epidemiological and Clinical Research Information Network
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
a) serious complications e.g. ischemic heart disease which is in need of treatment b) myocardial infarction developed within 6 momnths c) liver cirrhosis d) interstitial pneumonitis or pulmonary fibrosis which is in need of oxygen therapy e) fresh GI bleeding treated with repeated transfusion f) uncontrollable DM h) ileus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method